标题(英文):Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study 标题(中文):美国大型综合医疗系统中mRNA BNT162b2新冠疫苗接种后6个月内的有效性:一项回顾性队列研究 发表期刊:THE LANCET 作者单位:美国加利福尼亚...
BNT162b2 continued to be safe and have an acceptable adverse-event profile. Few participants had adverse events leading to withdrawal from the trial. Vaccine efficacy against Covid-19 was 91.3% (95% confidence interval [CI]...
标题(英文):Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study 标题(中文):美国大型综合医疗系统中mRNA BNT162b2新冠疫苗接种后6个月内的有效性:一项回顾性队列研究 发表期刊:THE LANCET 作者单位:美国加利福尼亚...
ANSWER:The Centers for Disease Control and Prevention has recommended the 2023-2024 COVID-19 (mRNA) vaccine for everyone 6 months or older. The COVID-19 vaccine is strongly recommended for people who face the highest risk of experiencing compl...
As a summer wave of COVID infections rolls across the country, U.S. health officials have recommended that all Americans over the age of 6 months get one of the updated COVID vaccines when they become available this fall.
(HealthDay)—There's good news for the millions of Americans who've already received a dose or two of Moderna's COVID-19 vaccine: New research shows the vaccine should protect against illness for at least six months. The new study tracked 33 participants in the trials that led to thevacc...
The data shows that the “known and potential benefits” of the vaccines outweigh any potential risks, the agency said. SUGGESTED for you TheModerna vaccineis authorized as a two-dose primary series in children 6 months to 17 years of age. ThePfizer vaccineis now authorized as a three-dose...
For the Moderna vaccine, the FDA amended the emergency use authorization (EUA) to include use of the vaccine in individuals 6 months through 17 years of age. The vaccine had previously been authorized for use in adults 18 years of age and older. ...
著名的英国医学杂志《柳叶刀》早在2022年2月4日就发表Peter Nordström(彼得·诺兹特儒姆)博士等人的论文“Risk of infection, hospitalization, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden”,中文为《瑞典的一项回顾性批量人口...
Article bySuman MPublished on: 1:55 am, 9 June 2021 The Covid-19 vaccine manufacturing companies Pfizer and Moderna said the vaccines for kids as young as 6 months old could be available soon, by the fall. Pfizer announced that it was testing its Covid-19 vaccine in 5 to 12 year-...